Answer
Safinamide is indicated for adults with idiopathic Parkinson’s disease who have mid- to late-stage fluctuations, as add-on therapy to a stable dose of levodopa, alone or combined with other Parkinson’s disease medicines.
Sources for this answer
- Safinamide 50 mg film-coated tabletsMSN Laboratories Europe Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked